Diseases & Disorders
(G30)
IRS Verified
DX Registered
990 on File
UNRAVEL
Financial strength (30%)
75/100
Reliability (20%)
50/100
Effectiveness (25%)
61/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Our mission is to bring hope to families battling childhood cancer by pursuing innovative research to find less toxic treatments that minimize harmful side effects and maximize survival rates. We are committed to unraveling the mysteries of cancer, exploring new therapeutic approaches and technologies, and relentlessly pursuing breakthroughs that will ultimately lead to a cure. Through collaboration with leading experts in the field, we envision a future where every child with cancer has access to safe, effective, and individualized treatments that provide the best chance for a healthy and happy life.
Financial Overview — FY 2023
$1.2M
Total Revenue
$1.0M
Total Expenses
$489K
Net Assets
5
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
58.3%
Fundraising Efficiency
N/A
Operating Reserve
5.73x
Liability-to-Asset
6.7%
Revenue Diversification
100.0%
Executive Compensation
$140K
Compared with Peers
FY 2023
Compared with 881 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
58.3% | 83.0% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
10.4% | 11.4% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
31.2% | 2.2% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
5.7 mo | 11.7 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
6.7% | 13.0% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.0% | 89.5% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
7.2% | 7.9% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-16.4% | 11.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
15.7% | 1.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $1.2M | $1.0M | $489K | 58.3% | 5 |
| 2022 | $1.1M | $1.2M | $298K | 50.4% | 5 |
| 2021 | $1.1M | $1.2M | N/A | — | 6 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.